Symrise Balance Sheet Health
Financial Health criteria checks 4/6
Symrise has a total shareholder equity of €3.8B and total debt of €2.4B, which brings its debt-to-equity ratio to 61.9%. Its total assets and total liabilities are €7.9B and €4.1B respectively. Symrise's EBIT is €619.7M making its interest coverage ratio 8. It has cash and short-term investments of €308.3M.
Key information
61.9%
Debt to equity ratio
€2.36b
Debt
Interest coverage ratio | 8x |
Cash | €308.26m |
Equity | €3.81b |
Total liabilities | €4.10b |
Total assets | €7.91b |
Recent financial health updates
Is Symrise (ETR:SY1) A Risky Investment?
Nov 20Is Symrise (ETR:SY1) Using Too Much Debt?
Jun 30Symrise (ETR:SY1) Has A Somewhat Strained Balance Sheet
Mar 08Recent updates
Is Symrise (ETR:SY1) A Risky Investment?
Nov 20Symrise AG's (ETR:SY1) Earnings Haven't Escaped The Attention Of Investors
Nov 05Calculating The Fair Value Of Symrise AG (ETR:SY1)
Oct 21Symrise's (ETR:SY1) Returns Have Hit A Wall
Sep 20Symrise AG (ETR:SY1) Interim Results: Here's What Analysts Are Forecasting For This Year
Aug 04With Symrise AG (ETR:SY1) It Looks Like You'll Get What You Pay For
Aug 04Calculating The Fair Value Of Symrise AG (ETR:SY1)
Jul 18Is Symrise (ETR:SY1) Using Too Much Debt?
Jun 30Symrise (ETR:SY1) Is Increasing Its Dividend To €1.10
Apr 26Investors Appear Satisfied With Symrise AG's (ETR:SY1) Prospects
Apr 24There Are Reasons To Feel Uneasy About Symrise's (ETR:SY1) Returns On Capital
Apr 09A Look At The Fair Value Of Symrise AG (ETR:SY1)
Mar 25Symrise (ETR:SY1) Has A Somewhat Strained Balance Sheet
Mar 08Why We're Not Concerned About Symrise AG's (ETR:SY1) Share Price
Jan 17Financial Position Analysis
Short Term Liabilities: SY1's short term assets (€2.7B) exceed its short term liabilities (€927.3M).
Long Term Liabilities: SY1's short term assets (€2.7B) do not cover its long term liabilities (€3.2B).
Debt to Equity History and Analysis
Debt Level: SY1's net debt to equity ratio (53.9%) is considered high.
Reducing Debt: SY1's debt to equity ratio has reduced from 101.5% to 61.9% over the past 5 years.
Debt Coverage: SY1's debt is well covered by operating cash flow (36.5%).
Interest Coverage: SY1's interest payments on its debt are well covered by EBIT (8x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 01:02 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Symrise AG is covered by 63 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Martin Schnee | AlphaValue |
Konstantin Wiechert | Baader Helvea Equity Research |
Volker Bosse | Baader Helvea Equity Research |